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Abstract
Genome-wide association studies (GWAS) comprise a powerful tool for mapping genes of complex traits. However, an
inflation of the test statistic can occur because of population substructure or cryptic relatedness, which could cause
spurious associations. If information on a large number of genetic markers is available, adjusting the analysis results by
using the method of genomic control (GC) is possible. GC was originally proposed to correct the Cochran-Armitage additive
trend test. For non-additive models, correction has been shown to depend on allele frequencies. Therefore, usage of GC is
limited to situations where allele frequencies of null markers and candidate markers are matched. In this work, we extended
the capabilities of the GC method for non-additive models, which allows us to use null markers with arbitrary allele
frequencies for GC. Analytical expressions for the inflation of a test statistic describing its dependency on allele frequency
and several population parameters were obtained for recessive, dominant, and over-dominant models of inheritance. We
proposed a method to estimate these required population parameters. Furthermore, we suggested a GC method based on
approximation of the correction coefficient by a polynomial of allele frequency and described procedures to correct the
genotypic (two degrees of freedom) test for cases when the model of inheritance is unknown. Statistical properties of the
described methods were investigated using simulated and real data. We demonstrated that all considered methods were
effective in controlling type 1 error in the presence of genetic substructure. The proposed GC methods can be applied to
statistical tests for GWAS with various models of inheritance. All methods developed and tested in this work were
implemented using R language as a part of the GenABEL package.
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Introduction
Genome-wide association studies (GWAS) are a powerful tool
for mapping genes of complex traits. Standard statistical methods
used for GWAS, such as linear regression, assume that the
correlation between a phenotype and a genotypic marker exists
because of the marker itself or a strong linkage disequilibrium with
the causative locus. This assumption holds when the sample
consists of representatives of one panmictic population. However,
other correlations caused by confounding factors that influence
both phenotypes and genotypes of various loci are possible. In
GWAS, the genetic substructure of the studied samples is among
the most important confounders. If the analysis is not accounted
for confounding by population substructure, the test statistic is
inflated [1], which makes its statistical interpretation difficult and
may lead to false-positive findings.
If information on a large number of genetic markers is available,
the analysis results can be adjusted by accounting for the influence
of non-specific effects by using the genomic control (GC) method.
Several methods have been proposed for GC adjustment [1–5].
Devlin and Roeder [1] suggested the use of a correction
coefficient, denoted as variance inflation factor (VIF), to correct
the distribution of the test statistic. In general, the VIF has been
demonstrated to be a function of marker allele frequencies and
population parameters [1]. It has also been deduced that for an
additive model, the VIF does not depend on allele frequency.
Thus, for an additive model, the ‘‘GC inflation factor’’ constant, l,
can be empirically estimated from null (not associated) loci. Note,
however, that for smaller allele frequencies and smaller samples
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asymptotic assumptions will not hold, and, consequently, the
inflation of the test statistic will depend on allele frequencies even
for additive model.
Several estimators of the Genomic Control inflation constant l
could be used. For example, the mean test statistic is an estimator
of l, which, however, suffers from being strongly affected by
outliers (e.g., from true association signals). The median estimator
(lmedian), which is defined as ratio of the median of the observed
distribution of the test statistic and 0.455 (the median of the x2df~1
distribution) [1], is probably the one used most. Another estimator
can be defined as regression coefficient of the observed test statistic
onto the statistic expected for the null loci (regression estimator
lregress). This estimator arises from the simple observation that the
covariance between two ordered random variables one of which is
distributed as x2df~1 and another as l*x
2
df~1 is equal to 2*l, while
the variance of the expected distribution is 2. All of these
estimators are constants that we can use as indicators of statistical
bias or as coefficients allowing correction of the observed test
statistic.
The general formulation of the VIF [2], in principle, allows for
extension of GC to dominant and recessive models. However, for
the non-additive model, the VIF depends on allele frequency and a
number of parameters that describe the genetic structure of the
sample. Thereby, it is possible to estimate the VIF empirically (as
for additive model) if the allele frequency of null loci is the same as
for the test locus (specific VIF for each allele group), but in this
case the number of available null markers is limited and thus limits
the applicability of the GC method. An alternative way requires
estimation of the population structure parameters. The methods,
which infer population structure and assign individuals to
populations [6] are computationally extensive.
Another method for empirical VIF estimation was suggested by
Zheng et al. [3] for .a two degrees of freedom (2df) model, which
does not constrain the relation of phenotypes and genotypes and
does not impose severe restrictions on the weight of the
heterozygous genotype. This ‘‘robust GC’’ method was based on
combining the corrected test statistics from dominant and recessive
models [3]. Yet another method of correction – delta decentral-
ization (based on centralization of the non-central chi-square) –
was proposed by Gorroochurn et al [7], but was later invalidated
by Dadd et. al. [8].
In this work, we aimed to develop and evaluate existing
methods for GC correction of results of GWAS using non-additive
(recessive, dominant, over-dominant, and 2df genotypic) models.
Therefore, we concentrate on several points: formulation of VIF
expressions for various models with one degree of freedom (1df)
and development of VIF-based procedures for GC correction of
the results of these models; estimation of model parameters
describing the population substructure for VIF estimation;
development of a new ‘‘polynomial’’ GC (PGC) method based
on a polynomial approximation of the correction coefficient that
can be applied for both one- and two-degree tests. All methods
were tested using simulated and real data.
Results
VIF for non-additive models
We derived the VIF as function of allele frequency (p), model of
inheritance (x indicates the effect of the heterozygous genotype; for
recessive, additive, and dominant model, x is equal to 0, 0.5, and 1,
respectively), sample size (N), and population parameters. The
over-dominant model (effect of genotype is equal to 0 for
homozygotes and to 1 for heterozygotes) is described separately.
Population parameters include the Wright’s coefficient of
inbreeding F (ranging from 0 to 1) [9] and a coefficient that
describes the population substructure, K~
P
ak{bkð Þ2 (K§0),
where ak and bk are numbers of representatives of each of the
subpopulations in case and control samples, respectively. In
reality, the mean inbreeding F takes a values of ,0.01 for most
populations, but can reach values of 0.04 for highly consanguin-
eous populations [10]. The value of K/N2 approaches zero when
the design is balanced (e.g. case:control ratio is 1:1 in each
subpopulation) and approaches its maximum of 1/2 when either
cases or controls only are sampled from each subpopulation.
The VIF is obtained as
l~
N Var Gið Þ{cov Gi,Gj
  
zK  cov Gi,Gj
 
NVar(Gj)
, where Gi is the
marker genotype of the i-th case (GiM {0,1,2}). Var(Gj) and
cov(Gi,Gj) is defined as:
Var(Gj)~ 2p(1{p)(1{F)x
2zFpz(1{F )p2
 
{
½2p(1{p)(1{F )xzFpz(1{F )p22
and
cov Gi,Gj
 
~{
2F(p{1)p(F3(p{1)p 1{2xð Þ2zF 2(p(8x{4){4xz3)
(Fz1)(2Fz1)
{
{
F ({3p2 1{2xð Þ2zp(2x{1)(6x{5){2(x{2)x)z2 {2pxzpzxð Þ2)
Fz1ð Þ 2Fz1ð Þ
respectively. The derivations and detailed formulas for the VIF are
provided in the Supplementary Note S1.
Figure 1 presents the VIF function for a set of population
parameters (F=0.05; N=1,000; K=11,000). This figure shows
that the VIF is independent of allele frequency only for the
additive model (x=K), which has been demonstrated previously
[2]. The function is point symmetric at x =K - recessive model is
mirror image of dominant. Also for x tending to infinity, it
approaches – as expected – the function for the over-dominant
model of inheritance.
Several conclusions could be drawn from the analysis of the VIF
function (Figure 1). First, the VIF of an additive model is always
greater than the one of non-additive models, which we also
observed in the analysis of simulated data for uncorrected tests
(Table 1). Second, the application of a naive correction by a
constant to the results obtained from the non-additive model
GWAS can fix the ‘‘average’’ type 1 error to the nominal level;
however, for several markers, the test will be conservative and for
others, it will be liberal. For example, for the dominant model,
such a ’’correction’’ will lead to a liberal test for low frequency
SNPs (single nucleotide polymorphisms) and to a conservative test
for common SNPs. These results are confirmed by our simulations
for constant correction tests (Table 1). Although the correction by
a constant generally keeps the type 1 error rate to a pre-defined
threshold, this is not true for SNPs in a particular frequency group.
Estimation of VIF parameters
Methods for VIF estimation require knowledge about param-
eters that describe the population substructure. If these parame-
ters, such as F and K, are not known, estimates can be utilized.
Estimation is based on the idea that the distribution of the analysis
test statistic should follow x2df~1 after correction. Thereby,
estimating unknown function parameters is possible by minimizing
a chosen error function that indicates the deviation of the observed
Genomic Control for Non-Additive Models
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distribution from the expected one. We used a sum of squared
deviations of the ordered corrected statistics (Z2) and the
theoretically expected distribution as an error function:
ferr~
XM
i~1
Z2i xð Þ
VIFi p,x,N,F ,Kð Þ{x
2
1
 2
Note that only the population parameters F and K should be
estimated, whereas N (sample size), M (number of SNPs), and p
and x are defined by the data and the analysis model. This method
was denoted as VIFGC.
Polynomial GC
We also propose a polynomial GC for non-additive models,
which approximates the correction function via an l-degree
polynomial of allele frequency p:
l(p)~
Xl
i~0
ai  pi
For estimation of the coefficients ai, we used the same idea as
with the estimation of parameters F and K in method VIFGC, that
is that the corrected statistic Z2~Z
2
l(p) should be distributed as
Figure 1. Dependence of VIF function on allele frequency p and model parameter x (F=0.05; N=1,000; K=11,000). (A) p: {0,1}, x:
{21,2}; (B) p: {0,1}, x = 0 (R, recessive), x = 1 (D, dominant), x = 1/2 (A, additive), x = 100 (O, over-dominant).
doi:10.1371/journal.pone.0081431.g001
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x2. We denote this method as PGC. Empirically, we decided to use
third degree polynomials during the optimization.
These two refined strategies, VIFGC and PGC, were compared
with the standard GC method of dividing test statistics by a
constant l. We used simulated and real data to evaluate the type 1
error and power of the methods. Type 1 error was characterized in
three ways: lmedian, which is the ratio of the observed distribution’s
median and the expected median (0.455); lregress, which is the
regression coefficient between the observed statistic’s distribution
and the theoretically expected x2 statistic; and E, which is the
proportion of tests with p-value # nominal level. We also
characterized the type 1 error in five specific marker allele
frequency groups: [0.05,0.25), [0.25,0.4), [0.4,0.6), [0.6,0.75), and
[0.75,0.95].
Simulation results
Simulation details could be found in the ‘‘Materials and
methods section’’. Simulation results for type 1 error for 1df tests
are presented in Table 1. As discussed above, constant corrected
tests have significant deviations from expected values of type 1
error for several allele frequency groups for non-additive models.
Unlike the constant correction method, the PGC and VIFGC
methods have a type 1 error close to expected values both for all
SNPs together and for specific frequency groups.
Simulation results for type 1 error for 2df tests are presented in
Table 2. This table shows that constant corrected tests have
slightly liberal type 1 error with a behavior similar to the additive
model, and the inflation does not depend on allele frequencies.
The method based on 1df VIFGC-corrected tests is strongly
conservative (the type 1 error is lower than the nominal level).
PGC corrected tests have type 1 error levels close to the nominal
level.
The power of different methods is shown in Table 3. It showed
that all methods for correction including VIFGC and PGC have
optimal power when the correct model (the one used in the
simulations) is also used for analysis. As expected, the 2df
genotypic test has less power but is robust compared with the
model used for simulation.
Application to real data
Real data application on two independent cohorts, namely,
Cooperative Health Research in the region of Augsburg (KORA)
and Erasmus Rucphen Family (ERF), provided the opportunity to
test our methods in situations that are not reflected in our
simulation study. In both studies, we analyzed imputed genotypes
(expressed as estimated probabilities) and quantitative traits using
linear regression methods. While our previous derivations and
results concern binary traits, an important previous observation for
Table 1. Type 1 error for one degree of freedom tests.
Not corrected Constant corrected VIFGC corrected PGC corrected
Model Frequency lmedian lregress E lmedian lregress E lmedian lregress E lmedian lregress E
Reccessive all 1.301 1.305 0.086 1.000 1.003 0.051 1.000 1.000 0.050 0.999 0.999 0.050
[0.05,0.25) 1.175 1.170 0.069 0.905 0.900 0.038 0.990 0.983 0.048 1.004 0.998 0.049
[0.25,0.4) 1.245 1.245 0.079 0.957 0.957 0.045 0.995 0.995 0.049 1.000 1.000 0.050
[0.4,0.6) 1.320 1.322 0.088 1.014 1.015 0.052 1.002 1.004 0.051 0.998 0.999 0.050
[0.6,0.75) 1.377 1.381 0.095 1.057 1.060 0.057 1.006 1.009 0.051 0.996 0.999 0.050
[0.75,0.95] 1.412 1.416 0.100 1.084 1.087 0.060 1.007 1.010 0.051 0.997 1.000 0.050
Additive all 1.453 1.458 0.104 1.000 1.003 0.051 0.997 1.000 0.050 0.991 1.034 0.050
[0.05,0.25) 1.451 1.455 0.104 0.998 1.001 0.050 0.995 0.998 0.050 0.991 1.033 0.050
[0.25,0.4) 1.455 1.460 0.105 1.001 1.005 0.051 0.998 1.002 0.050 0.991 1.035 0.050
[0.4,0.6) 1.456 1.461 0.105 1.002 1.006 0.051 0.999 1.002 0.051 0.990 1.035 0.050
[0.6,0.75) 1.454 1.458 0.104 1.000 1.003 0.051 0.997 1.000 0.050 0.990 1.034 0.050
[0.75,0.95] 1.452 1.456 0.104 0.999 1.002 0.051 0.996 0.998 0.050 0.992 1.036 0.050
Dominant all 1.302 1.306 0.086 1.000 1.003 0.051 0.999 1.000 0.050 0.999 1.000 0.050
[0.05,0.25) 1.413 1.416 0.099 1.084 1.086 0.060 1.007 1.009 0.051 0.997 0.999 0.050
[0.25,0.4) 1.379 1.383 0.095 1.058 1.061 0.057 1.007 1.010 0.051 0.997 1.000 0.050
[0.4,0.6) 1.320 1.323 0.088 1.013 1.016 0.052 1.002 1.004 0.051 0.998 1.001 0.050
[0.6,0.75) 1.244 1.245 0.079 0.956 0.956 0.045 0.993 0.993 0.049 1.000 1.000 0.050
[0.75,0.95] 1.174 1.171 0.070 0.903 0.900 0.039 0.988 0.984 0.048 1.003 0.999 0.050
Over-dominant all 1.176 1.181 0.072 1.000 1.004 0.051 0.999 1.000 0.050 0.999 1.000 0.050
[0.05,0.25) 1.281 1.282 0.083 1.088 1.089 0.061 1.007 1.008 0.051 0.996 0.997 0.050
[0.25,0.4) 1.143 1.146 0.067 0.972 0.974 0.047 0.998 1.000 0.050 1.006 1.008 0.051
[0.4,0.6) 1.060 1.058 0.057 0.902 0.901 0.039 0.987 0.985 0.048 0.991 0.990 0.049
[0.6,0.75) 1.142 1.143 0.067 0.971 0.972 0.047 0.998 0.999 0.050 1.006 1.007 0.051
[0.75,0.95] 1.279 1.282 0.083 1.086 1.089 0.060 1.007 1.008 0.051 0.996 0.997 0.050
Type 1 error was estimated in three ways: lmedian, which is the ratio of observed distribution’s median and expected median; lregress, which is the regression coefficient
between observed statistic’s distribution and theoretically expected Chi-square statistic; and E, which is the proportion of the tests with p-value#0.05. The values are
given for all SNPs as well as for stratified frequency groups.
doi:10.1371/journal.pone.0081431.t001
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the GC was that the method can be applied in the framework of
quantitative trait regression analysis models as well [11].
It should be noted, that for genome-wide analyses in ERF,
mixed model based methods are used [12]; here, however, we use
ERF as an example of highly genetically structured population,
and analyze it using fixed effects-only model. In KORA, we
analyzed uric acid levels, and in ERF, levels of high-density
lipoprotein (HDL) (see ‘‘Materials and Methods’’ section for more
details).
Table 4 shows the results of type 1 error analysis in ERF, a
family-based study where the association is strongly confounded by
the genetic structure if naı¨ve analysis is applied. When an additive
model is used without correcting for genetic structure via mixed
models, l for HDL is 1.2. For non-additive models, we reproduced
the same principal findings that we obtained from simulated data
by using these real data. Correction by a constant factor results in
a conservative test for some frequency groups and in a liberal test
for other frequency groups, whereas VIFGC and PGC corrections
yield accurate levels independent of the marker allele frequency.
Type 1 error results in KORA, a population-based study where
stratification is minimal, are presented in Table 5. When an
additive model is used, we observe that l is only 1.03 for the
quantitative trait uric acid. For non-additive models, where the
genetic structure is close to absent in this data set, we still
reproduced the same principal findings as observed in our
simulations and analysis of ERF data.
Discussion
We demonstrated by simulations and the analysis of real data
that the proposed GC methods (VIFGC and PGC) could be used
for the correction of non-additive test statistics in the context of
GWAS assuming different models of inheritance. For additive
models, widely used in GWAS, there are two applications of GC
methods. Firstly, the inflation coefficient l can be used to correct
the test statistic, thereby making an interpretation of p-values
statistically valid. Secondly, l serves as an important indicator of
goodness of the model used for association analysis. Although no
specific threshold is available, as a rule, if the inflation of the test
statistics is relatively large, this reflects the fact that the model
chosen for analysis poorly accounts for the genetic structure
present in the sample. In that case, the analysis model should be
revised, e.g., instead of standard linear regression, the use of a such
methods as structured association, EIGENSTRAT [13] or mixed
models [14–16] should be considered. Note that even after the
most advanced analysis model is used, some residual inflation may
be expected. This residual inflation is usually corrected by the GC,
because even minor inflation still can lead to much increased false
positive rate in GWAS. For example, at l=1.05, when the test
statistic is not corrected, the x2 threshold of 29.72 (p-val-
ue = 5*1028 in case the statistic is not inflated) corresponds to p-
value = 1*1027, that is the false positive rate is increased by more
than two times. This correction is also very important when meta-
analysis of multiple GWAS is performed [17] because a small
residual inflation, when not corrected, can lead to very large
inflation in the final meta-analysis test statistic.
In our examples involving analysis of real phenotypes, the main
use of GC in ERF is the use as indicator. Although nominal type I
error can be achieved with the GC, GWAS should be performed
with mixed models in this population, and GC should be used only
to correct residual inflation. Analysis of KORA, which is a
carefully designed population-based study with little stratification,
Table 2. Type 1 error for two degrees of freedom tests.
Not corrected Constant corrected df1 based (VIFGC corrected)* PGC corrected
Frequency lmedian lregress E lmedian lregress E lmedian lregress E lmedian lregress E
all 1.239 1.250 0.092 1.000 1.009 0.053 0.951 0.957 0.045 0.991 1.000 0.051
[0.05,0.25) 1.239 1.248 0.091 1.000 1.007 0.052 0.959 0.962 0.045 0.992 1.000 0.051
[0.25,0.4) 1.241 1.252 0.092 1.001 1.010 0.053 0.948 0.955 0.045 0.991 1.000 0.051
[0.4,0.6) 1.240 1.252 0.092 1.001 1.010 0.053 0.942 0.951 0.044 0.990 1.000 0.051
[0.6,0.75) 1.239 1.251 0.092 1.000 1.009 0.053 0.946 0.955 0.045 0.990 1.000 0.052
[0.75,0.95] 1.239 1.249 0.092 1.000 1.008 0.053 0.959 0.963 0.045 0.992 1.000 0.051
The abbreviations are as in Table 1. The values are given for all SNPs as well as for stratified frequency groups.
*2df test based on 1df corrected tests (here, 1df tests were corrected by VIFGC) [3].
doi:10.1371/journal.pone.0081431.t002
Table 3. Power (% of test with p-value#0.05) for different tests.
Simulated model Recessive Additive Dominant Over-dominant
Analised model r a d o g r a d o g r a d o g r a d o g
Not corrected 0.87 0.71 0.26 0.44 0.78 0.60 0.78 0.64 0.42 0.67 0.20 0.74 0.84 0.39 0.78 0.37 0.32 0.40 0.83 0.76
Constant corrected 0.79 0.59 0.15 0.43 0.64 0.48 0.67 0.58 0.38 0.62 0.15 0.63 0.80 0.35 0.72 0.31 0.26 0.33 0.78 0.60
VIF corrected* 0.80 0.59 0.16 0.41 0.62 0.50 0.66 0.55 0.38 0.58 0.15 0.63 0.80 0.35 0.68 0.30 0.26 0.32 0.77 0.57
PGC corrected 0.81 0.58 0.16 0.41 0.63 0.50 0.67 0.56 0.38 0.62 0.15 0.64 0.80 0.36 0.72 0.30 0.26 0.32 0.77 0.59
*genotypic model for VIFGC corrected tests is a two degrees of freedom test based on recessive and dominant tests corrected by VIFGC [3].
r, a, d, o, and g are recessive, additive, dominant, over-dominant, and genotypic models, respectively.
doi:10.1371/journal.pone.0081431.t003
Genomic Control for Non-Additive Models
PLOS ONE | www.plosone.org 5 December 2013 | Volume 8 | Issue 12 | e81431
provides a more realistic example of a case when the GC method
should be used ‘‘directly’’.
Most GWAS performed up-to-date have used an additive
model, and GC is an essential part of the analysis procedure.
Methods for GC for non-additive models are much less developed.
This obstructs correct analysis, meta-analysis, and interpretation of
the results of such GWAS. Despite weaker development of the
methodological base, some works reported interesting findings
based on the analysis of non-additive models [18–21].
In this work, we proposed new and study existing methods of
GC for non-additive models. We demonstrated that the VIFGC
and the PGC method can be used to correct the results of GWAS
obtained by using dominant, recessive, over-dominant (one degree
of freedom), and genotypic (two degrees of freedom) models. We
show that in general, for 1df models, both VIFGC and PGC
perform equally well, whereas for the 2df model, the test based on
a 1df VIFGC-corrected statistic results in a conservative test.
Thus, for the genotypic model, the PGC correction may be
preferred. These methods have a variance of the type 1 error in all
frequency groups that is significantly less than that observed when
constant correction GC is applied (p,10220, see Table S4). It
should be noted that for the PGC method we could in principle
use an exponential function instead of a polynomial, but using of
exponential function restricts the available models to the recessive
and dominant only. Using polynomial functions eliminates
restrictions for using PGC for other models, such as overdominant
and the 2df genotypic ones.
However, the quality of approximation comes at the costs of
time whereas the correction of the additive model’s results is
computationally very simple, the VIFGC and PGC corrections
include parameter optimization steps. Still, even PGC that
requires optimization of four parameters and uses the data from
2.5 million tests finishes within minutes on a standard PC.
In our methods, we estimated the parameters by using the
regression loss function. This loss function is sensitive to possible
heavy tails of the distribution (these may reflect real strong
association signals). Therefore, we decided to use the lower 95%
of the distribution, which is similar to the method suggested in [22].
Other solutions are possible by using different loss functions, which
are less sensitive to outliers. Examples include loss functions defined
by the sum of absolute deviations or the square root thereof and the
difference between obtained and expected medians.
For additive models, the GC inflation factor l is an important
indicator of goodness of the model used for association analysis.
For recessive, dominant, and over-dominant models, we have
demonstrated that the test inflation is always smaller than the
inflation for the additive model (Figure 1). Therefore, we suggest
that the use of analytical method that appropriately reflects the
Table 4. Type 1 error in ERF data analysis.
Not corrected Constant corrected VIFGC corrected* PGC corrected
Model Frequency lmedian lregress E lmedian lregress E lmedian lregress E lmedian lregress E
Recessive all 1.201 1.200 0.074 1.000 1.000 0.050 1.001 1.000 0.050 1.000 1.000 0.050
[0.05,0.25) 1.105 1.109 0.063 0.921 0.924 0.042 0.993 0.997 0.050 0.998 1.002 0.051
[0.25,0.5) 1.188 1.180 0.072 0.989 0.983 0.048 1.005 0.999 0.050 0.998 0.992 0.050
[0.5,0.75) 1.240 1.252 0.079 1.033 1.043 0.055 1.004 1.013 0.051 0.996 1.006 0.051
[0.75,0.95] 1.273 1.261 0.081 1.061 1.051 0.056 1.001 0.991 0.049 1.008 0.999 0.050
Additive all 1.298 1.302 0.086 1.000 1.003 0.051 0.997 1.000 0.050 0.996 1.000 0.050
[0.05,0.25) 1.299 1.290 0.085 1.001 0.994 0.050 0.998 0.991 0.049 1.008 1.000 0.050
[0.25,0.5) 1.298 1.313 0.088 1.001 1.012 0.052 0.997 1.008 0.052 0.986 0.997 0.050
[0.5,0.75) 1.301 1.320 0.088 1.003 1.017 0.053 1.000 1.014 0.052 0.989 1.003 0.051
[0.75,0.95] 1.292 1.286 0.084 0.995 0.991 0.049 0.992 0.988 0.049 1.003 0.999 0.050
Dominant all 1.202 1.203 0.074 1.000 1.001 0.050 1.000 1.000 0.050 1.000 1.000 0.050
[0.05,0.25) 1.277 1.265 0.081 1.063 1.053 0.056 1.001 0.991 0.049 1.008 0.999 0.050
[0.25,0.5) 1.243 1.252 0.079 1.035 1.042 0.054 1.003 1.011 0.051 0.997 1.005 0.051
[0.5,0.75) 1.190 1.183 0.072 0.990 0.985 0.049 1.005 1.000 0.050 0.999 0.994 0.050
[0.75,0.95] 1.104 1.112 0.064 0.919 0.925 0.042 0.991 0.998 0.050 0.995 1.002 0.051
Over-dominant all 1.133 1.123 0.064 1.000 0.991 0.049 1.011 1.000 0.050 1.011 1.000 0.050
[0.05,0.25) 1.203 1.193 0.072 1.061 1.053 0.056 1.017 1.010 0.051 1.011 1.003 0.050
[0.25,0.5) 1.076 1.060 0.057 0.950 0.935 0.043 1.011 0.995 0.049 1.013 0.998 0.049
[0.5,0.75) 1.064 1.053 0.056 0.939 0.929 0.042 1.000 0.989 0.049 1.004 0.993 0.049
[0.75,0.95] 1.204 1.190 0.072 1.062 1.050 0.056 1.017 1.007 0.051 1.014 1.004 0.051
Genotypic (df = 2) all 1.157 1.162 0.077 1.000 1.004 0.052 0.964 0.966 0.046 0.996 1.000 0.051
[0.05,0.25) 1.163 1.159 0.077 1.005 1.002 0.052 0.973 0.969 0.047 1.004 1.001 0.051
[0.25,0.5) 1.152 1.165 0.077 0.996 1.006 0.052 0.954 0.964 0.045 0.988 0.999 0.051
[0.5,0.75) 1.151 1.164 0.077 0.995 1.006 0.052 0.953 0.963 0.046 0.989 1.000 0.051
[0.75,0.95] 1.163 1.159 0.077 1.005 1.001 0.052 0.973 0.970 0.047 1.004 1.000 0.052
*for VIFGC corrected genotypic (2df) tests, we used the 1df based test by performing VIFGC-corrected tests for recessive and dominant models [3].
The abbreviations are as in Table 1. The values are given for all SNPs as well as for stratified frequency groups.
doi:10.1371/journal.pone.0081431.t004
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genetic structure of the underlying data should be decided based
on l for an additive model or based on the maximal value of the
VIF function from the non-additive model.
For the GC method, an important previous observation was
that the method is not specific for the Cochran-Armitage test.
Bacanu et. al. [11] have demonstrated earlier that the GC method
can be applied in the framework of quantitative trait regression
analysis models as well, including models with gene-gene
interaction. We confirmed this principle by analyzing real
quantitative trait in two different populations.
All methods developed and tested in this work were implemented
in R language in the GenABEL-package [23], part of the GenABEL
project for statistical genomics (http://www.genabel.org).
In summary, we proposed and tested several methods for GC for
various models of inheritance and compared these methods by using
real and simulated data. We demonstrated that the VIFGC and the
PGC method can be successfully used in adjusting the test statistic
for different non-additive models in the framework of GWAS.
Materials and Methods
ERF study
Simulations were based on real genetic data collected in the
framework of the Erasmus Rucphen Family (ERF) study. All study
protocols were approved by the Medical Ethics Committee of
Erasmus University, and all participants gave written informed
consent in accordance with the Declaration of Helsinki. The ERF
study is a cross-sectional study embedded in genetically isolated
population located in southwest Netherlands. The study partici-
pants are members of a single large pedigree that can be traced in
23 generations and contains thousands of cycles [24]. The sample
used for simulations included 3,235 people, for whom the
genotypes of 54,000 SNP markers were available. All SNPs
included had a coding allele frequency (CAF) 0.05#CAF (coded
allele frequency) #0.95 and a call rate $0.95.
In the example where real phenotypic data was used, we
analyzed levels of high-density lipoprotein (HDL) on imputed
genotypic data. This data set included 2,699 people, who were
genotyped and imputed (using HapMap2 as reference panel) at
2,093,818 SNP markers. All SNPs in the subset had
0.05#CAF#0.95 and a call rate$0.95. More detailed description
of phenotyping and sample can be found in [25].
KORA study
As an example of a carefully designed population-based
study, we used KORA (Cooperative Health Research in the
region of Augsburg) F4, which is a study from the KORA cohorts
[26]. KORA F4 is a follow-up (from 2006 to 2008) of the
Table 5. Type 1 error of KORA data tests.
Not corrected Constant corrected VIFGC corrected* PGC corrected
Model Frequency lmedian lregress E lmedian lregress E lmedian lregress E lmedian lregress E
Recessive all 1.016 1.020 0.053 1.000 1.004 0.051 0.996 1.000 0.050 0.996 1.000 0.050
[0.05,0.25) 1.015 1.016 0.052 0.998 1.000 0.050 1.004 1.005 0.051 1.000 1.001 0.050
[0.25,0.5) 1.014 1.023 0.053 0.998 1.006 0.051 0.996 1.005 0.051 0.992 1.001 0.050
[0.5,0.75) 1.017 1.021 0.053 1.001 1.005 0.051 0.993 0.997 0.050 0.993 0.997 0.050
[0.75,0.95] 1.020 1.020 0.053 1.004 1.004 0.051 0.993 0.993 0.050 1.000 1.001 0.051
Additive all 1.019 1.024 0.053 1.000 1.005 0.051 0.995 1.000 0.050 0.995 1.000 0.050
[0.05,0.25) 1.024 1.030 0.053 1.005 1.011 0.051 1.000 1.006 0.051 0.997 1.003 0.050
[0.25,0.5) 1.020 1.024 0.053 1.001 1.004 0.051 0.996 0.999 0.050 0.994 0.998 0.050
[0.5,0.75) 1.017 1.019 0.052 0.998 1.000 0.050 0.993 0.995 0.050 0.994 0.996 0.050
[0.75,0.95] 1.016 1.024 0.053 0.997 1.005 0.051 0.992 1.000 0.050 0.995 1.003 0.051
Dominant all 1.021 1.025 0.053 1.000 1.004 0.051 0.996 1.000 0.050 0.996 1.000 0.050
[0.05,0.25) 1.024 1.026 0.053 1.002 1.005 0.051 0.989 0.992 0.049 0.999 1.002 0.050
[0.25,0.5) 1.025 1.028 0.054 1.004 1.007 0.051 0.995 0.999 0.050 0.994 0.998 0.050
[0.5,0.75) 1.015 1.026 0.053 0.994 1.005 0.051 0.992 1.003 0.050 0.987 0.997 0.050
[0.75,0.95] 1.022 1.021 0.053 1.000 1.000 0.050 1.007 1.007 0.051 1.003 1.002 0.050
Over-dominant all 1.027 1.027 0.053 1.000 1.000 0.050 1.000 1.000 0.050 1.000 1.000 0.050
[0.05,0.25) 1.027 1.027 0.054 1.000 1.001 0.051 0.987 0.988 0.049 0.999 1.000 0.050
[0.25,0.5) 1.029 1.027 0.053 1.003 1.000 0.050 1.016 1.013 0.051 1.003 1.001 0.050
[0.5,0.75) 1.028 1.025 0.053 1.002 0.998 0.050 1.014 1.011 0.051 1.002 0.999 0.050
[0.75,0.95] 1.021 1.028 0.054 0.995 1.001 0.051 0.982 0.988 0.049 0.994 1.000 0.051
Genotypic (df = 2) all 1.021 1.024 0.054 1.000 1.003 0.051 0.999 1.002 0.051 0.997 1.000 0.051
[0.05,0.25) 1.021 1.022 0.054 1.000 1.001 0.051 0.997 0.998 0.050 1.000 1.001 0.051
[0.25,0.5) 1.022 1.026 0.055 1.001 1.005 0.051 0.997 1.001 0.051 0.996 1.000 0.051
[0.5,0.75) 1.020 1.024 0.054 0.999 1.003 0.051 0.996 0.999 0.050 0.994 0.998 0.050
[0.75,0.95] 1.021 1.025 0.055 1.000 1.004 0.052 1.006 1.009 0.052 0.997 1.001 0.051
*for VIFGC corrected genotypic (2df) tests, we used the 1df based test by performing VIFGC-corrected tests for recessive and dominant models [3].
The abbreviations are as in Table 1. The values are given for all SNPs as well as for stratified frequency groups.
doi:10.1371/journal.pone.0081431.t005
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population-based KORA S4 study that was conducted in the
region of Augsburg in Southern Germany from 1999 to 2001. All
study protocols were approved by the ethics committee of the
Bavarian Medical Chamber (Bayerische Landesa¨rztekammer),
and all participants gave written informed consent. In our
application, we analyzed levels of uric acids in a data set including
1,788 people who were genotyped with the Affymetrix 6.0 SNP
array (730,525 SNP markers after quality control) with further
imputation using HapMap2 (release 22) as reference panel
resulting in a total of 2,210,193 SNPs. All SNPs in the study
had 0.05#CAF#0.95 and a call rate $0.95. A more detailed
description of study design, genotyping, and phenotyping is
reported in [27].
Simulations
The phenotypes for analysis of type 1 error and the power were
simulated based on real genetic data from the ERF study by using
the scheme described below. We used binary traits for simulations
because in our own derivation of VIF as well as in previous
derivations, binary traits were used in the same way as
demonstrated in [2]. Results can be generalized to quantitative
traits as well [11].
Liability values were simulated as a sum of independent
quantitative trait loci (QTLs) and polygenic effects. The heritabil-
ity coefficient was set to be equal to a random number coming
from a uniform distribution bounded by 0.5 and 0.8. To model the
QTL effect, an SNP was randomly chosen. Based on its minor
allele frequency (MAF), the effect was assigned in a way that the
SNP was accounted for 0% of total liability variance for type 1
error and 0.35% for power simulations. To model the polygenic
effect, 500 markers were randomly chosen (excluding the
chromosome harboring the QTL), and based on their allele
frequencies, effects were assigned in such way that each of the
SNPs explained the same fraction of non-QTL heritability. The
quantitative phenotype was transformed into a binary trait
following a threshold model (the ‘‘case’’ phenotype was assigned
if liability was below the threshold corresponding to 1/3 of the
distribution). To study type 1 error, 1,000 simulation cycles were
performed. To study the power, 100 simulation cycles were
performed.
Association analysis
For the analysis of simulated and real data, we used standard
tests implemented in the GWFGLS (genome-wide feasible
generalized least squares) function of the MixABEL package,
which is a part of the GenABEL suite of programs [23] for
statistical genomics (option ‘‘score,’’ so the output from GWFGLS
for binary traits was completely the same as for Cochran-Armitage
trend test of chi-square for binary traits). GWAS were calculated
for five different (additive, dominant, recessive, over-dominant,
and genotypic) models of SNP effect.
For quantitative trait analysis, we used regression and score test
as implemented in MixABEL. For the analysis of imputed data,
the regression was performed onto probabilities.
GWAS results were corrected using different methods for GC.
The standard method, which corrects test statistic by dividing it by
the estimated l, was applied as well as two refined methods. The
qualities of the GC correction methods were compared with one
another in terms of type 1 error with three characteristics:
lmedian: ratio of distribution’s median and expected median
(0.455)
lregress: regression coefficient between statistic’s distribution and
theoretically expected Chi-square statistic
E: proportion of the tests with p-value less then declared level
(0.05).
In addition to the comparison of the performance for all SNPs,
five allele frequency groups were compared separately: [0.05,0.25),
[0.25,0.4), [0.4,0.6), [0.6,0.75), and [0.75,0.95].
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